DB17357InvestigationalProtein Based Therapies
AMG 424 is a novel, humanized, anti-CD3/CD38 bispecific monoclonal antibody being investigated for multiple myeloma.
- Also known as
- Humanized Bi-Specific Xmab(R) T Cell Recruiting Antibody Construct Directed Against Cd3 And Cd38
- Code names
- AMG 424
What you can answer from here — as of April 23, 2025
Which companies are running trials of AMG 424, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account